Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.13 USD
Change Today +0.03 / 0.33%
Volume 56.9K
MDGN On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

medgenics inc (MDGN) Key Developments

Medgenics, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Medgenics, Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, operating loss was USD 7,888,000 against USD 5,235,000 a year ago. Loss before taxes on income was USD 8,921,000 against USD 5,352,000 a year ago. Loss was USD 8,922,000 against USD 5,357,000 a year ago. Basic and diluted loss per share was USD 0.36 against USD 0.28 a year ago.

Medgenics, Inc., Q1 2015 Earnings Call, Apr 17, 2015

Medgenics, Inc., Q1 2015 Earnings Call, Apr 17, 2015

Medgenics, Inc., Annual General Meeting, Apr 16, 2015

Medgenics, Inc., Annual General Meeting, Apr 16, 2015., at 10:00 US Eastern Standard Time. Location: The Westin New York at Times Square, 270 West 43rd Street. Agenda: To consider and elect seven persons to serve on Board of Directors until the next annual meeting of stockholders and until their respective successors are duly elected and qualified; to consider and ratify the appointment of Kost Forer Gabbay & Kasierer a member of Ernst & Young Global, as independent registered public accounting firm for the fiscal year ending December 31, 2015; and to consider and transact such other proper business as may come before the meeting and any adjournment or postponement at the meeting.

Medgenics, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:30 PM

Medgenics, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:30 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Medgenics, Inc. Announces Audited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Medgenics, Inc. announced audited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported a loss of $6.20 million or $0.30 per share, compared with a loss of $5.21 million or $0.28 per share for the comparative quarter in 2013. For the period, the company reported operating loss of $12,628,000 against $17,818,000 a year ago. Loss before taxes on income was $15,052,000 against $17,112,000 a year ago. Loss was $15,071,000 or $1.37 per diluted share against $17,129,000 or $1.06 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGN:US $9.13 USD +0.03

MDGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGN.
View Industry Companies
 

Industry Analysis

MDGN

Industry Average

Valuation MDGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 9.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDGENICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.